Single Source Justification MPT to SAT - 9 9 26_Redacted.pdf
PDF 404 KB Posted
- Solicitation number
- 36C25627Q0016
About this file
This is a Justification for Single Source Award document submitted by the Department of Veterans Affairs, Network Contracting Office (NCO) 16, for the Central Arkansas Veterans Healthcare System in Little Rock, Arkansas.
The Pathology & Laboratory Medicine Service requires advanced immunohematology reference laboratory services to support safe blood transfusion practices at VA medical centers. The required services include red cell phenotyping, complex antibody identification using gel methodology, molecular blood typing/genotyping, and comprehensive serologic investigations. These services must be performed accurately and consistently within a single accredited facility to ensure methodological correlation and clinically reliable interpretation. The base performance period runs from November 2, 2026, to October 1, 2027, with four optional one-year extensions through October 1, 2031. The estimated annual amount and total contract value (base plus options) are redacted in the document.
The justification establishes that Versiti Inc. is the only known source capable of delivering the complete spectrum of advanced immunohematology services using gel methodology within a single accredited facility. Market research identified that while other commercial laboratories such as Quest Diagnostics, LabCorp, Mayo Clinic Laboratories, and Oklahoma Blood Institute can perform portions of the required services, none can deliver the full menu at one location using gel methodology aligned with VA practices. The justification notes that fragmenting services across multiple vendors would create unacceptable patient-safety risks through increased specimen transport delays, inconsistent methodologies, and inability to reliably prevent transfusion reactions for transfusion-dependent Veterans. The Contracting Officer certified the purchase on September 9, 2026, in accordance with FAR 13.106-1(b), and determined that a small business set-aside is not appropriate for this acquisition.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C25627A0010_1.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Revision: 02 Effective Date: 12/30/2025 Page 1 of 3 Acquisition ID#
DEPARTMENT OF VETERANS AFFAIRS
Justification for Single Source Awards IAW FAR 13.106-1 For
Over Micro-Purchase Threshold but Not Exceeding the Simplified Acquisition Threshold
Acquisition Plan Action ID:_
1. Contracting Activity: Network Contracting Office (NCO) 16 in support of
Department of Veterans Affairs, VISN 16, Central Arkansas Veterans Healthcare System, 4300 West 7th Street, Little Rock, AR 72205.
Purchase Request:
2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount: The Pathology & Laboratory Medicine Service (P&LMS) requires advanced immunohematology reference laboratory services to support safe and accurate blood transfusion practices at VA medical centers. The Contractor shall perform red cell phenotyping, complex antibody identification using gel methodology, molecular blood typing/genotyping, and comprehensive serologic investigations. Results will be used by VA blood banks and clinical teams to determine donor–recipient compatibility, prevent transfusion reactions, and support patient care decisions.
Period of Performance:
BASE Year: 11/2/2026 to 10/01/2027
Option Year 1: 11/02/2027 to 10/01/2028
Option Year 2: 11/02/2028 to 10/01/2029
Option Year 3: 11/03/2029 to 10/01/2030
Option Year 4: 11/03/2030 to 10/01/2031
Estimated Amount: Annually Total (Base plus four options):
3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used:
VA medical centers require advanced immunohematology reference laboratory services to support safe and accurate transfusion practices. These services include red cell phenotyping, complex antibody identification using gel methodology, molecular blood typing/genotyping, and comprehensive serologic investigations all of which must be performed accurately, consistently, and within a single accredited facility.
Revision: 02 Effective Date: 12/30/2025 Page 3 of 3 Acquisition ID# at one facility at a fair and reasonable price. Accordingly, a set‑aside is not appropriate for this action.
5. Contracting Officer's Certification: Purchase is approved in accordance with FAR
13.106-1(b). I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.
____________________________ __9/9/2026________________ Date
Contracting Officer
File details come from the government source that posted it. Updated .